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Cinnamon supplementation improves  
blood pressure in type 2 diabetic patients: 
A systematic review and meta-analysis  
of randomized controlled trials
ABSTRACT
Some studies have suggested that consumption of 
some herbal medicines may improve blood pressure. 
The present systematic review and meta-analysis 
was conducted to assess the efficacy of cinnamon 
supplementation on blood pressure in type 2 diabetic 
patients.
The systematic search was undertaking using several 
online databases (PubMed, Embase, Scopus and Web 
of Sciences) to identify randomized controlled trials 
(RCTs) investigating the effect of cinnamon supple-
mentation on systolic blood pressure (SBP) or diastolic 
blood pressure (DBP) in type 2 diabetic patients that 
were published up until 10 December 2019. Potential 
publication bias was assessed using the Egger regres-
sion test.
Five full-text articles were included in this meta-
-analysis. Pooled results of the meta-analysis on 332 
participants indicated a significant reduction in SBP 
and DBP following cinnamon administration. No pub-
lication bias was found.
The results of the present study suggested that cinna-
mon might be effective in improving blood pressure 
in type 2 diabetic patients. (Clin Diabetol 2020; 9; X 
XXX–XXX)
Key words: cinnamon, blood pressure, 
cardiovascular, nutrition, meta-analysis
Introduction
Hypertension is one of the most common adult 
chronic disorders and affects approximately 25% of 
the adult population and 8.5% of diabetic patients 
globally. The complications of hypertension is also 
estimated to cause 7 million deaths annually [1, 2]. 
There is an urgent need to improve the control blood 
pressure in hypertensive patients, as guideline recom-
mended targets are often not adequately attained us-
ing current drug treatment. It has been reported that 
only approximately 50% of people with hypertension 
have controlled BP (less than 140/90 mm Hg), whereas 
more than 13% of patients have systolic (SBP) > 160 
mm Hg and/or diastolic blood pressure (DBP) > 100 
mm Hg [3]. Moreover, the complications and adverse 
effects of antihypertensive drugs as well as their high 
costs appear to reduce the adherence to treatment of 
hypertensive patients [4]. Hence alternative, or com-
plementary medicines, for hypertension are receiving 
some interest.
Recently, there has been more attention focused 
on using nutritional and bioactive compounds for 
prevention of chronic illnesses and enhancement of 
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well-being [5]. Cinnamomum (Cinnamon) is a genus 
from the Lauraceae family of plants and is considered 
to be a dietary herbal medicine [6]. Cinnamon has 
been reported to have numerous properties, including 
antidiabetic, anti-inflammatory, lipid-lowering, anti-
oxidant, antimicrobial, and anticancer properties [7]. 
It has also been suggested that it could be used as an 
herbal remedy for the treatment of several disorders 
including cardiovascular diseases, type 2 diabetes, 
chronic digestive difficulties, and Alzheimer’s disease 
[8]. Some previous studies have reported that cinnamon 
supplementation can significantly reduce systolic and 
diastolic blood pressure in the subjects with type 2 
diabetes mellitus [9–11]. The results of some other 
studies have not been consistent [12, 13]. Therefore, 
the effect of cinnamon intake on the systolic and di-
astolic blood pressure remains unclear. Disagreements 
among the findings of published trials might be due 
to the differences in dosage of cinnamon used, study 
design, characteristics of study populations, and dura-
tion of the trials. 
The present meta-analysis aimed to assess the ef-
fect of cinnamon supplementation on the blood pres-
sure and anthropometric parameters as known critical 
risk factors for hypertension.
Methods
The present meta-analysis was conducted as 
recommended by the Preferred Reporting Items for 
Systematic reviews and Meta-Analyses (PRISMA) [14].
Systematic search
Our systematic search was undertaken using sev-
eral online databases: PubMed, Embase, Scopus and 
Web of Sciences, to identify randomized controlled 
trials (RCTs) investigating the effects of cinnamon 
supplementation on blood pressure in type 2 diabetic 
patients for all potential publication from the earliest 
available time up to 10th December 2019. The following 
search strategy was used without any time or language 
limitation: [Keywords for supplement] AND [Keywords 
for outcomes] AND [Keywords for disease] AND [Key-
words for study design]. To complete search process, 
Google scholar, Cochrane Library and list of relevant 
references were then hand-searched to identify eligible 
papers that might have been missed.
Inclusion and exclusion criteria 
Relevant articles were selected for meta-analysis 
that met the following inclusion criteria: (1) being a 
RCT, (2) using cinnamon as supplement in confirmed 
type 2 diabetic patients, (3) reporting sufficient data 
for baseline and final trials of SBP or/and DBP in both 
cinnamon and control groups, (4) human studies and 
(5) English languages publication. Unpublished data 
and gray literature, such as conference abstracts, book 
chapters, editorials and letters and the like, studies 
conducted on other types of diabetes or related dis-
orders, healthy and just glucose-intolerant subjects 
were excluded. 
Data extraction
Eligible articles were abstracted by two reviewers 
separately and following information were extracted 
using a pre-defined form: last name of first author, 
publication year, country, sample size, age of partici-
pants, target population, intervention duration, dose of 
cinnamon, type of the supplement and mean changes/ 
/standard deviation (SD) of the outcomes. Net changes 
were calculated by subtracting pre-test from post-test. 
Also, SD for changes was obtained using the following 
formula: √ ([(SD pre)2 + (SD post)2] – [2r × SD pre × SD 
post]) [15], with considering coefficient correlation (r) 
as 0.5. Furthermore, any doubts were clarified through 
a discussion with the third reviewer.
Risk of bias assessment
The Cochrane Collaboration risk of bias Tool [16] 
was used to qualify the included RCTs based on fol-
lowing criteria: “randomization generation, allocation 
concealment, blinding of participants and outcome 
assessors, incomplete outcome data, selective outcome 
reporting and other sources of bias”. Any discrepancy 
was discussed between the two reviewers and resolved 
by corresponding author.
Statistical analysis
STATA software (version 13) was used to analyze 
the data. Due to a high degree of heterogeneity 
among the included RCTs, random-effects model 
was used to calculate the mean difference (MD) and 
its 95% confidence intervals (CI). To identify statisti-
cal heterogeneity, I2 (high ≥ 50%, low < 50%) and 
P-value (significant < 0.05) were used. Random-
-effects meta-regression was applied by mean age 
of participants, duration of intervention and dose of 
cinnamon to seek the potential sources of statistical 
heterogeneity between studies. Furthermore, sub-
group analyses by treatment duration (2 months, 
3 months), baseline SBP (> 134 mm Hg, < 134 mm Hg) 
and dosage (> 1.7 gram/day, < 1.7 gram/day) were 
performed. Also, Sensitivity analysis was undertaken 
to evaluate the impact of each study on the pooled 
results. Egger’s test was applied to detect potential 
publication bias [17]. A P < 0.05 was considered as 
statistically significant.
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Results
Literature search
As shown in Figure 1, 865 papers regarding the 
effect of cinnamon supplementation on blood pressure 
were identified from online databases. Of these, 430 du-
plicate papers were excluded; 435 articles remained for 
title/abstract screening and 420 records were removed. 
Then, at the final step, 15 articles were assessed for eli-
gibility and full-text screening. After full-text assessment, 
5 articles were included in the present meta-analysis.
Study characteristics
Table 1 outlines the main characteristics of the 
included trials. Five trials were published from 2010 
to 2016, which were conducted in Asia and Europe. 
Study sample sizes ranged from 19 to 49 participants 
in the intervention group and 18 to 50 subjects in the 
controls. A total number of participant that was in-
cluded in this meta-analysis was 332. The minimum and 
maximum mean age of the subjects in the treatment 
group was 54.9–61.7 years, respectively. The duration 
of the interventions was 2 months in three studies and 
3 months in the two other studies. The minimum dose 
of cinnamon supplementation among the studies was 
1.2 gram/day and the maximum was 3 grams/day. All 
of the included trials used oral cinnamon as the sup-
plement. The methodological quality and risk of bias 
of the included RCTs based on authors’ judgment is 
shown in Table 2.
Effect of cinnamon supplementation  
on blood pressure
Pooled effects of 5 datasets (Figure 2) revealed 
a significant reduction in SBP (MD = –0.53, 95% 
CI = [–1.03, –0.02], P = 0.04, I2 = 79.8%) following 
cinnamon administration compared with the control 
participants. Furthermore, high heterogeneity was 
decreased following subgroup analysis (Table 3) by 
baseline SBP (> 134 mm Hg), treatment duration 
(2 months) and doses less than 1.7 gram/day. 
Studies included in quantitative 
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Figure 1. Flow diagram of data selection process
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Moreover, from the current meta-analysis we found 
that DBP was significantly affected by cinnamon sup-
plementation (MD = –0.70, 95% CI = [–1.30, –0.07], 
P = 0.03, I2 = 86.0%) in type 2 diabetic patients as 
compared with the control group. Also, high statistical 
heterogeneity decreased following subgroup analyses 
(Table 3) by baseline SBP (> 134 mm Hg), intervention 
duration (3 months) and doses less than 1.7 gram/day.
Meta-regression
As shown in Table 4, meta-regression of SBP and 
DBP could not identify the potential source of hetero-
geneity by mean age, duration and dose of cinnamon.
Publication bias and sensitivity analysis
No significant publication bias was found for both 
SBP (P = 0.60) and DBP (P = 0.78). Also, impact of each 
trial on the pooled result was checked and showed that 
the results of the present study were not affected by 
removing one study at a time.
Discussion
To the best of our knowledge, this is the first 
study to review the available literature and recent 
randomized clinical trials (RCTs) regarding the effects 
of cinnamon supplementation on blood pressure in 
diabetic patients as a meta-analysis. The results of this 
study demonstrated that cinnamon supplementation 
significantly reduced systolic blood pressure. But there 
was a high heterogeneity among studies regarding the 
effects of cinnamon on SBP and this was reduced by 
sub-group analysis and considering different features 
of the included studies such as duration, dose of sup-
plementation, and baseline BP. Moreover, patients with 
type 2 diabetes receiving cinnamon supplement also 
showed significant improvements in DBP compared 
with the control group. 
Many studies have evaluated and confirmed the 
hypotensive effects of cinnamon [9, 18, 19]. Our results 
were also in line with the results of a study by Akilen 
et al. as they demonstrated that cinnamon supple-
mentation could significantly decrease SBP in diabetic 
patients [10]. Furthermore, our results also confirmed 
the results of a study by Sengsuk et al. regarding the 
blood pressure-lowering effects of cinnamon [11]. 
A possible explanation for the effects of cinna-
mon on BP might be related to its active components, 
including: cinamaldehyde, cinnomic acid, eugenol, 
Table 1. Demographic characteristics of the included RCTs
First author (year) Publication 
year
Country Sample size  
(intervention/ 
/control) 
Intervention 
groups age, 
mean (SD)
Population Duration Dose 
(gram/ 
/day)
Type of  
supplement
Akilen et al. [10] 2010 United 
Kingdom
30/28 54.9 (10.14) T2DM 3 months 2 Capsule
Wainstein et al. [13] 2011 Israel 29/30 61.7 (6.3) T2DM 3 months 1.2 Capsule
Vafa et al. [34] 2012 Iran 19/18 54.11 (10.37) T2DM 2 months 3 Capsule
Sengsuk et al. [11] 2016 Thailand 49/50 57.2 (1.1) T2DM 2 months 1.5 Capsule
Azimi et al. [18] 2016 Iran 40/39 54.15 (1) T2DM 2 months 3 Powder
T2DM — type 2 diabetes mellitus
Table 2. Methodological quality assessment of the included studies
Study Sequence 
generation
Allocation 
conceal-
ment
Blinding Blinding  
of outcome 
assessment
Incomplete 
outcome  
data
Selective  
reporting
Other  
biases
Sengsuk (2016) [11] + + + + + + +
Azimi (2016) [18] + + + – ? + +
Vafa et al. [34] ? ? + + + + +
Wainstein (2011) [13] + + + + + – ?
Akilen (2010) [10] + + + + + + +
+  — low risk; –  – high risk; ?  – unclear
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and coumarin [19]. Some of the flavonoids and phy-
tochemicals in cinnamon might cause endothelial 
relaxation. Cinnamon has been reported to increase 
the levels of cyclic guanosine monophosphate (cGMP) 
that can mediate the nitric oxide (NO) production and 
help the relaxation of vascular smooth muscle [20]. In 
addition, active ingredients of cinnamon might exert 
an anti-hypertensive effects through their cholinergic 
and diuretic properties [21, 22]. Another mechanism 
regarding the anti-hypertensive effects of cinnamon 
is related to its effects as an antioxidant and hypo-
glycemic agent that both are completely pertinent to 
the improvement of endothelial dysfunction [10, 23]. 
In diabetic patients, these effects may be more pro-
nounced. Normal vascular contraction through normal 
Ca2+ influx via insulinotropic effects of cinnamon is 
the main cause of hypotensive effect of cinnamon in 
diabetic patients [24].
Cinnamon may also have BP-lowering properties 
through peripheral vasodilation [25]. Furthermore the 
potential beneficial effect of cinnamon may be ex-
plained by its effect on increasing estimated glomerular 
filtration rate. The damaging effects of hypertension 
may in part be due to its effects on the kidney which 
might be attenuated by cinnamon ingestion [26]. In 
one study, the effects of cinnamon on reducing vascular 
cell-adhesion molecule-1 and SICAM-1 was reported 
that was mediated through inhibiting the expression of 
endothelial factors at the transcriptional level especially 
by decreasing mRNAs [27]. Additionally, it seems that 
cinnamon might mediate antihypertensive effects by 
improving arterial wall compliance [28]. It can also en-
hance NO production according to one previous study 
[29]. Moreover, cinnamon can alleviate hyperuricemia 
[30, 31], resting tachycardia, nerve traffic, and high 
plasma norepinephrine [32], that may all be associated 
with better BP control. 
Another important point in the current analysis 
is about the difference between studies regarding 
the cinnamon dose that was evaluated by sub-group 
analysis. It was shown that the hypotensive effects of 
cinnamon on SBP and DBP were significant at doses of 
< 1.7 g/day and > 1.7 g/day, respectively. Finding an 
exact dose of cinnamon for improving cardio-metabolic 
MD (95% CI) 
MD (95% CI) 
Weight (%)
Weight (%)
Study (year) 
Study (year) 
Note: Weights are from random effects analysis
Note: Weights are from random effects analysis
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Figure 2. Forest plot detailing MDs and 95% CIs for the meta-analyses of SBP (A) and DBP (B)
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Table 4. Meta-regression of SBP and DBP by mean age, duration and dose
Covariates Coefficient P-value 95% CI Tau2
SBP, overall Tau2 = 6.75
Mean age 0.73 0.40 –6.04, 7.50 7.76
Duration 1.95 0.50 –23.46, 27.37 8.85
Dose 5.44 0.23 –21.71, 32.61 4.176
DBP, overall Tau2 = 8.92
Mean age –0.24 0.66 –1.90, 1.40 11.06
Duration –0.39 0.90 –10.42, 9.63 11.85
Dose 2.46 0.20 –2.32, 7.26 6.25
CI — confidence intervals; SBP — systolic blood pressure; DBP — diastolic blood pressure
Table 3. Subgroup analyses of SBP and DBP based on publication year, intervention duration and dose
Subgroup Effect size MD 95% CI Overall P Heterogeneity (I2/P)
SBP
Baseline SBP
> 134 mm Hg 2 –0.463 –0.779, –0.147 0.004 0.0%/0.896
< 134 mm Hg 3 –0.575 –1.587, 0.437 0.265 89.9%/< 0.0001
Intervention duration
3 months 2 –1.062 –2.201, 0.078 0.068 87.9%/0.004
2 months 3 –0.239 –0.509, 0.030 0.082 0.20%/0.367
Dose
> 1.7 g/day 3 –0.575 –1.587, 0.437 0.265 89.9%/< 0.0001
< 1.7 g/day 2 –0.779 –0.779, –0.147 0.004 0.0%/0.896
DBP
Baseline SBP
> 134 mm Hg 2 –0.292 –0.606, –0.022 0.068 0.0%/0.373
< 134 mm Hg 3 –0.976 –1.940, –0.012 0.047 88.4%/< 0.0001
Intervention duration
3 months 2 –0.400 –0.979, 0.179 0.176 59.6%/0.116
2 months 3 –0.868 –1.886, 0.151 0.095 91.3%/< 0.0001
Dose
> 1.7 g/day 3 –0.976 –1.940, –0.012 0.047 88.4%/< 0.0001
< 1.7 g/day 2 –0.292 –0.606, 0.022 0.068 0.0%/0.373
MD — mean difference; CI — confidence intervals; SBP — systolic blood pressure; DBP — diastolic blood pressure
factors may be challenging, especially because of 
the effects of cinnamon on inhibiting blood clotting 
due to its coumarin content and considering the fact 
that many diabetic or cardiovascular patients are re-
ceiving anticoagulants [33]. Hence, interpreting the 
dose-effect of cinnamon is not easy and should be 
interpreted with caution. Further investigations are 
warranted to clarify the exact safe dose of cinnamon 
for controlling BP. 
On the other hand, effects of cinnamon on re-
ducing SBP was more pronounced in studies done 
for shorter durations (in 2 months compared with 
3 months). This is in accordance with the results of the 
study done by Sengsuk et al. [11]. It is unclear whether 
this is due to compliance, or tachyphylaxis.
Another point to mention is that the effect of cin-
namon supplementation on SBP is more pronounced 
in those with higher baseline SBP, as reported by Azimi 
and her colleagues [18]. 
It is also important to mention that the results of 
the current meta-analysis was not determined by  any 
single study as assessed by sensitivity analysis.  
The results of the current meta-analysis pooled the 
available RCTs according to the effects of cinnamon on 
BP control. However, this study has several weakness 
and the results should be interpreted with caution. 
Ronak Jalali et al., Cinnamon supplementation improves blood pressure in type 2 diabetic patients 
185
It only includes five studies, and, there was high degree of 
heterogeneity among studies. However, the sub-group 
analysis considered the differences among studies 
including dose, duration, and baseline BP values and 
their effects on changes in BP following cinnamon 
supplementation, and another strength of the current 
study, was the inclusion of trials that were not restricted 
to a specific country or region and our results could 
generalize to the different ethnic groups.
Conclusion
To sum up, in this systematic review and meta-
analysis, oral cinnamon supplementation could reduce 
BP. More RCTs with various doses are recommended to 
be able to draw a final conclusion. Additionally, more 
animal or human studies are warranted to elucidate the 
exact safe and effective dose of cinnamon supplement 
for controlling BP in cardio-metabolic or diabetic patients.
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